Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine versus intravenous ketorolac for renal colic pain
IRCT20180526039846N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nephrolithiasis comparing Intranasal ketamine with Intravenous ketorolac control (2 arms). Primary endpoints: Renal colic pain intensity at 90 minutes and Side effects at 90 minutes. Started Aug 2018; status: completed.
02
Drugs
ketamineketorolac
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20180526039846N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180526039846N1.